Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun 10:7:19-25.
doi: 10.4137/CGM.S11288. eCollection 2014.

Cancer chemoprevention: current state of the art

Affiliations
Review

Cancer chemoprevention: current state of the art

Kristin R Landis-Piwowar et al. Cancer Growth Metastasis. .

Abstract

The aim of cancer chemoprevention is disruption or delay of the molecular pathways that lead to carcinogenesis. Chemopreventive blocking and/or suppressing agents disrupt the molecular mechanisms that drive carcinogenesis such as DNA damage by reactive oxygen species, increased signal transduction to NF-κB, epigenomic deregulation, and the epithelial mesenchymal transition that leads to metastatic progression. Numerous dietary phytochemicals have been observed to inhibit the initiation phase of carcinogenesis, and therefore are useful in primary chemoprevention. Moreover, phytochemicals are capable of interfering with the molecular mechanisms of metastasis. Likewise, numerous synthetic compounds are relevant and clinically viable as chemopreventive agents during the fundamental stages of carcinogenesis. While molecularly targeted anti-cancer therapies are in constant stages of development, superior patient outcomes are observed if carcinogenic processes are prevented altogether. This article reviews the role of chemopreventive compounds in inhibition of cancer initiation and their ability to reduce cancer progression.

Keywords: blocking agents; chemoprevention; phytochemicals; suppressing agents.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mechanism of Nrf2 signaling and activation of antioxidant gene expression. Nrf2 is sequestered in the cytoplasm by Keap1. In response to external stressors (eg oxidants and electrophiles), Nrf2 is released from Keap1 and translocates to the nucleus where it forms a heterodimer with Maf that binds to antioxidant-responsive elements (ARE). The Nrf2–Maf heterodimer increases transcription of genes downstream from the ARE that encode detoxifying and antioxidant enzymes such as GST and NQO1. These cytoprotective enzymes limit the effects of electrophiles and oxidants on DNA and help preserve genomic integrity. Abbreviations: Nrf2, NF-E2-related factor 2; Keap1, Kelch-like ECH-associating protein 1; GST, glutathione S-transferase; NQO1, NADPH: quinone oxidoreductase 1.

References

    1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29. - PubMed
    1. Wu X, Patterson S, Hawk E. Chemoprevention—history and general principles. Best Pract Res Clin Gastroenterol. 2011;25:445–459. - PubMed
    1. De Flora S, Ferguson LR. Overview of mechanisms of cancer chemopreventive agents. Mutat Res. 2005;591:8–15. - PubMed
    1. Steward WP, Brown K. Cancer chemoprevention: a rapidly evolving field. Br J Cancer. 2013;109:1–7. - PMC - PubMed
    1. Shu L, Cheung KL, Khor TO, Chen C, Kong AN. Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis. Cancer Metastasis Rev. 2010;29:483–502. - PubMed

LinkOut - more resources